NCT00783354View on ClinicalTrials.gov

A Comparison of Aerius Continuous Treatment Versus Aerius PRN for Chronic Idiopathic Urticaria (Study P03147)

PHASE4CompletedINTERVENTIONAL
Enrollment

129

Participants

Timeline

Start Date

April 1, 2003

Primary Completion Date

February 1, 2004

Study Completion Date

April 1, 2004

Conditions
UrticariaChronic Idiopathic Urticaria
Interventions
DRUG

desloratadine

"Patients received desloratadine 5 mg daily, given as one tablet in the evening, and were asked to take one tablet of rescue medication (Placebo) in case of symptoms for 2 months."

DRUG

desloratadine

"Patients received Placebo daily, given as one tablet in the evening, and were asked to take one tablet of rescue medication (desloratadine 5 mg) in case of symptoms for 2 months."

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00783354 - A Comparison of Aerius Continuous Treatment Versus Aerius PRN for Chronic Idiopathic Urticaria (Study P03147) | Biotech Hunter | Biotech Hunter